Irene Olivera

1.1k total citations
24 papers, 544 citations indexed

About

Irene Olivera is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Irene Olivera has authored 24 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 18 papers in Oncology and 4 papers in Genetics. Recurrent topics in Irene Olivera's work include CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (12 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Irene Olivera is often cited by papers focused on CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (12 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Irene Olivera collaborates with scholars based in Spain, United Kingdom and United States. Irene Olivera's co-authors include Ignacio Melero, Pedro Berraondo, Assunta Cirella, Álvaro Teijeira, Saray Garasa, Miguel F. Sanmamed, María C. Ochoa, Iñaki Eguren‐Santamaría, Carlos Luri‐Rey and Carlos E. de Andrea and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Science Advances.

In The Last Decade

Irene Olivera

24 papers receiving 537 citations

Peers

Irene Olivera

IMMUN

ONCOL

GENET

Samuel Alsén Sweden

Ekaterina Zmievskaya Russia

Tiziano Ingegnere Italy

Tamara Laskowski United States

Amanda N. Henning United States

Valentina Casella Spain

Ting Lu United States

Anniek B. van der Waart Netherlands

Katy J. McCann United Kingdom

Mara Valentini Italy

Samuel Alsén Sweden

Irene Olivera

513 ×1.4

IMMUN

277 ×1.1

ONCOL

191 ×1.4

56 ×1.0

GENET

34 ×0.6

Citations per year, relative to Irene Olivera Irene Olivera (= 1×) peers Samuel Alsén

Countries citing papers authored by Irene Olivera

Since Specialization

Citations

This map shows the geographic impact of Irene Olivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Olivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Olivera more than expected).

Fields of papers citing papers by Irene Olivera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Olivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Olivera. The network helps show where Irene Olivera may publish in the future.

Co-authorship network of co-authors of Irene Olivera

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Olivera. A scholar is included among the top collaborators of Irene Olivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Olivera. Irene Olivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olivera, Irene, et al.. (2024). Regional and intratumoral adoptive T-cell therapy. Immuno-Oncology Technology. 24. 100715–100715. 4 indexed citations

Olivera, Irene, Assunta Cirella, Myriam Fernández-Sendin, et al.. (2023). Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis. Journal for ImmunoTherapy of Cancer. 11(11). e006702–e006702. 8 indexed citations

Olivera, Irene, Elixabet Bolaños, Sandra Hervás‐Stubbs, et al.. (2023). mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy. Cell Reports Medicine. 4(3). 100978–100978. 32 indexed citations

Álvarez, Maite, Carmen Molina, Saray Garasa, et al.. (2023). Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic. OncoImmunology. 12(1). 2197370–2197370. 10 indexed citations

Glez‐Vaz, Javier, Arantza Azpilikueta, María C. Ochoa, et al.. (2023). CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects. Science Advances. 9(33). eadf6692–eadf6692. 6 indexed citations

Olivera, Irene, Carlos Luri‐Rey, Álvaro Teijeira, et al.. (2023). Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy. Clinical Cancer Research. 29(23). 4711–4727. 2 indexed citations

Ochoa, María C., Carlos E. de Andrea, Saray Garasa, et al.. (2023). Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma. Cell Reports Medicine. 4(4). 101009–101009. 16 indexed citations

Cirella, Assunta, Elixabet Bolaños, Carlos Luri‐Rey, et al.. (2023). Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists. Molecular Therapy — Nucleic Acids. 33. 668–682. 6 indexed citations

Cirella, Assunta, Myriam Fernández-Sendin, Irene Olivera, et al.. (2022). Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8 ⁺ T cells eradicates peritoneal metastases in mouse models. OncoImmunology. 12(1). 2147317–2147317. 9 indexed citations

10.

Glez‐Vaz, Javier, Arantza Azpilikueta, Irene Olivera, et al.. (2022). Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies. Journal for ImmunoTherapy of Cancer. 10(3). e003532–e003532. 13 indexed citations

11.

Teijeira, Álvaro, Saray Garasa, Carlos Luri‐Rey, et al.. (2022). Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy. Cancer Research. 82(23). 4373–4385. 22 indexed citations

12.

Cirella, Assunta, Carlos Luri‐Rey, Álvaro Teijeira, et al.. (2022). Novel strategies exploiting interleukin-12 in cancer immunotherapy. Pharmacology & Therapeutics. 239. 108189–108189. 74 indexed citations

13.

Teijeira, Álvaro, Itziar Miguéliz, Saray Garasa, et al.. (2022). Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers. Theranostics. 12(3). 1373–1387. 33 indexed citations

14.

Glez‐Vaz, Javier, Arantza Azpilikueta, Irene Olivera, et al.. (2022). Abstract 628: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies. Cancer Research. 82(12_Supplement). 628–628. 1 indexed citations

15.

Olivera, Irene, Elixabet Bolaños, Sandra Hervás‐Stubbs, et al.. (2022). 267 mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy. Regular and Young Investigator Award Abstracts. A282–A282. 1 indexed citations

16.

Teijeira, Álvaro, Saray Garasa, María C. Ochoa, et al.. (2021). Differential Interleukin‐8 thresholds for chemotaxis and netosis in human neutrophils. European Journal of Immunology. 51(9). 2274–2280. 41 indexed citations

17.

Fernández-Sendin, Myriam, Assunta Cirella, Irene Olivera, et al.. (2021). Advances in mRNA-based drug discovery in cancer immunotherapy. Expert Opinion on Drug Discovery. 17(1). 41–53. 18 indexed citations

18.

Olivera, Irene, et al.. (2020). Vaginal neutrophils eliminate sperm by trogocytosis. Human Reproduction. 35(11). 2567–2578. 20 indexed citations

19.

Olivera, Irene, et al.. (2019). Estradiol impairs epithelial CXCL1 gradient in the cervix to delay neutrophil transepithelial migration during insemination. Journal of Reproductive Immunology. 132. 9–15. 8 indexed citations

20.

Olivera, Irene, Lara Matilla, Jennifer Brazil, et al.. (2018). Estrogen Receptor-Alpha (ESR1) Governs the Lower Female Reproductive Tract Vulnerability to Candida albicans. Frontiers in Immunology. 9. 1033–1033. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact